{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:08:11Z","timestamp":1778850491882,"version":"3.51.4"},"posted":{"date-parts":[[2026,5,13]]},"group-title":"Neurology","reference-count":43,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,5,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Cognitive impairment is a major source of disability in Parkinsonian disorders, yet biomarkers that distinguish cognitive status from cognitive decline remain limited. DNA methylation-based epigenetic aging measures capture complementary dimensions of biological aging, but it remains unclear whether they primarily reflect stable differences in cognitive vulnerability or longitudinal cognitive change. We examined associations between epigenetic aging measures and global cognition in the Parkinson\u2019s Progression Markers Initiative (PPMI) cohort. Seven epigenetic aging measures were derived from peripheral blood DNA methylation data, and cognition was assessed longitudinally using the Montreal Cognitive Assessment (MoCA). Linear mixed-effects models were applied in complementary frameworks, including baseline-plus-change-from-baseline models and within-person versus between-person decomposition models. Secondary analyses included baseline clock-by-time interaction models and a decline-focused sensitivity analysis. Across analyses, higher epigenetic aging was consistently associated with lower overall MoCA scores. In the baseline-plus-change-from-baseline models, the analytic baseline component showed the dominant signal, whereas the change-from-baseline terms were not significant after false discovery rate correction. In the within-person versus between-person decomposition models, associations were concentrated in the between-person component, while within-person deviation terms were not significant. Secondary analyses were consistent with this pattern. Together, these findings suggest that blood-based epigenetic aging measures may be more informative as biomarkers of cognitive status or vulnerability than as markers of short-term cognitive progression. Larger studies with longer follow-up and more detailed cognitive phenotyping are needed to clarify their longitudinal relevance.<\/jats:p>","DOI":"10.64898\/2026.05.11.26352912","type":"posted-content","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:15:15Z","timestamp":1778714115000},"source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic Aging Clocks Associate with Cognitive Status but Not Cognitive Decline: Evidence from the Parkinson\u2019s Progression Markers Initiative"],"prefix":"10.64898","author":[{"given":"Bowen","family":"Feng","sequence":"first","affiliation":[{"name":"The Hospital for Sick Children, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Gao","sequence":"additional","affiliation":[{"name":"Adlai E. Stevenson High School, Lincolnshire, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyun","family":"Yang","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, IL, USA"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026051505201790000_2026.05.11.26352912v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.08.034"},{"key":"2026051505201790000_2026.05.11.26352912v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70152-7"},{"issue":"4","key":"2026051505201790000_2026.05.11.26352912v1.3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"2026051505201790000_2026.05.11.26352912v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(19)30024-9"},{"issue":"1","key":"2026051505201790000_2026.05.11.26352912v1.5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","article-title":"Aging and aging-related diseases: from molecular mechanisms to interventions and treatments","volume":"7","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2026051505201790000_2026.05.11.26352912v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2021.01.003"},{"key":"2026051505201790000_2026.05.11.26352912v1.7","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-10-r115"},{"key":"2026051505201790000_2026.05.11.26352912v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.10.016"},{"issue":"4","key":"2026051505201790000_2026.05.11.26352912v1.9","first-page":"573","article-title":"An epigenetic biomarker of aging for lifespan and healthspan","volume":"10","year":"2018","journal-title":"Aging (Albany NY"},{"issue":"2","key":"2026051505201790000_2026.05.11.26352912v1.10","first-page":"303","article-title":"DNA methylation GrimAge strongly predicts lifespan and healthspan","volume":"11","year":"2019","journal-title":"Aging (Albany NY"},{"issue":"23","key":"2026051505201790000_2026.05.11.26352912v1.11","first-page":"9484","article-title":"DNA methylation GrimAge version 2","volume":"14","year":"2022","journal-title":"Aging (Albany NY"},{"key":"2026051505201790000_2026.05.11.26352912v1.12","doi-asserted-by":"crossref","unstructured":"Belsky, D.W. , et al., DunedinPACE, a DNA methylation biomarker of the pace of aging. Elife, 2022. 11.","DOI":"10.7554\/eLife.73420"},{"key":"2026051505201790000_2026.05.11.26352912v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-022-00085-y"},{"key":"2026051505201790000_2026.05.11.26352912v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102552"},{"key":"2026051505201790000_2026.05.11.26352912v1.15","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glab047"},{"issue":"3","key":"2026051505201790000_2026.05.11.26352912v1.16","doi-asserted-by":"crossref","first-page":"e70010","DOI":"10.1002\/dad2.70010","article-title":"Epigenetic age acceleration and cognitive performance over time in older adults","volume":"16","year":"2024","journal-title":"Alzheimers Dement (Amst"},{"key":"2026051505201790000_2026.05.11.26352912v1.17","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000200898"},{"key":"2026051505201790000_2026.05.11.26352912v1.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2010.02982.x"},{"issue":"12","key":"2026051505201790000_2026.05.11.26352912v1.19","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"The Parkinson\u2019s progression markers initiative (PPMI) - establishing a PD biomarker cohort","volume":"5","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"2026051505201790000_2026.05.11.26352912v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2011.09.005"},{"key":"2026051505201790000_2026.05.11.26352912v1.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"2026051505201790000_2026.05.11.26352912v1.22","doi-asserted-by":"crossref","unstructured":"Julayanont, P. and Z.S. Nasreddine , Montreal Cognitive Assessment (MoCA): Concept and Clinical Review, in Cognitive Screening Instruments: A Practical Approach, A.J. Larner , Editor. 2017, Springer International Publishing: Cham. p. 139-195.","DOI":"10.1007\/978-3-319-44775-9_7"},{"key":"2026051505201790000_2026.05.11.26352912v1.23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175674"},{"key":"2026051505201790000_2026.05.11.26352912v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.03.006"},{"key":"2026051505201790000_2026.05.11.26352912v1.25","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1142558"},{"key":"2026051505201790000_2026.05.11.26352912v1.26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c34b47"},{"key":"2026051505201790000_2026.05.11.26352912v1.27","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu049"},{"key":"2026051505201790000_2026.05.11.26352912v1.28","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx513"},{"key":"2026051505201790000_2026.05.11.26352912v1.29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts680"},{"key":"2026051505201790000_2026.05.11.26352912v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxj037"},{"key":"2026051505201790000_2026.05.11.26352912v1.31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2026.03.006","article-title":"Associations of epigenetic age acceleration with motor impairment: Evidence from the Parkinson\u2019s Progression Markers Initiative cohort","volume":"164","year":"2026","journal-title":"Neurobiol Aging"},{"key":"2026051505201790000_2026.05.11.26352912v1.32","unstructured":"Team, R.C ., R: A Language and Environment for Statistical Computing. 2024, R Foundation for Statistical Computing: Vienna, Austria."},{"key":"2026051505201790000_2026.05.11.26352912v1.33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209699"},{"key":"2026051505201790000_2026.05.11.26352912v1.34","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26170"},{"key":"2026051505201790000_2026.05.11.26352912v1.35","doi-asserted-by":"crossref","first-page":"2633105520942221","DOI":"10.1177\/2633105520942221","article-title":"DNA Methylation Clocks and Their Predictive Capacity for Aging Phenotypes and Healthspan","volume":"15","year":"2020","journal-title":"Neurosci Insights"},{"key":"2026051505201790000_2026.05.11.26352912v1.36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.parkreldis.2018.06.031","article-title":"Predicting early cognitive decline in newly-diagnosed Parkinson\u2019s patients: A practical model","volume":"56","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2026051505201790000_2026.05.11.26352912v1.37","first-page":"19","article-title":"Are Standardized Tests Sensitive to Early Cognitive Change in Parkinson\u2019s Disease?","volume":"53","year":"2023","journal-title":"Psychopharmacol Bull"},{"issue":"4-6","key":"2026051505201790000_2026.05.11.26352912v1.38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000496454","article-title":"Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson\u2019s Disease","volume":"47","year":"2019","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"6","key":"2026051505201790000_2026.05.11.26352912v1.39","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3233\/JPD-223433","article-title":"Parkinson\u2019s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson\u2019s Disease Progression","volume":"13","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"2026051505201790000_2026.05.11.26352912v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16391-5"},{"key":"2026051505201790000_2026.05.11.26352912v1.41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.psyneuen.2019.01.028","article-title":"The role of epigenetic aging in education and racial\/ethnic mortality disparities among older U","volume":"104","year":"2019","journal-title":"S. Women. Psychoneuroendocrinology"},{"key":"2026051505201790000_2026.05.11.26352912v1.42","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa334"},{"issue":"9","key":"2026051505201790000_2026.05.11.26352912v1.43","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1111\/ejn.15661","article-title":"A comparison of blood and brain-derived ageing and inflammation-related DNA methylation signatures and their association with microglial burdens","volume":"56","year":"2022","journal-title":"Eur J Neurosci"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.05.11.26352912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:20:26Z","timestamp":1778847626000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.05.11.26352912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":43,"URL":"https:\/\/doi.org\/10.64898\/2026.05.11.26352912","relation":{},"subject":[],"published":{"date-parts":[[2026,5,13]]},"subtype":"preprint"}}